Jonathan Anderman
Insider (Form 4 reporting owner): General Counsel CIK 2032625Name as filed: Anderman JonathanIts filings on EDGARAll insiders
Measures activity, not value. Not investment advice.
Since 7 Apr 2025, bought $31K in 1 open-market purchase of Compass Therapeutics.
Companies
Role on the latest Form 4 for each; open-market trades counted| Company | Role | Trades from | to | Purchases | Sales |
|---|---|---|---|---|---|
| Compass Therapeutics CMPX | General Counsel | 7 Apr 2025 | 29 Apr 2026 | 1$31K | – |
What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.
Median return minus the sector fund, in percentage points; "too few trades" under 5| Open-market trades | After 3 months | After 6 months | After 12 months |
|---|---|---|---|
| After purchases | too few trades1 trade | too few trades1 trade | too few trades1 trade |
For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.
By year
Counted open-market trades, by trade date| Year | Purchases | Bought | Sales | Sold | Net |
|---|---|---|---|---|---|
| 2025 | 1 | $31K | – | – | $31K |
Every trade
2, newest first; open-market purchases and sales only| Trade date | Company | Side | Shares | Price | Value | Planned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. | Filing |
|---|---|---|---|---|---|---|---|
| 29 Apr 2026 | Compass Therapeutics CMPX | Buyamended filing (4/A), not counted again | 25,000 | $1.89 | $47K | No | Form 4/Afiled 30 Apr 2026 |
| 7 Apr 2025 | Compass Therapeutics CMPX | Buy | 20,000 | $1.54 | $31K | No | Form 4filed 8 Apr 2025 |
From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.